Click on the slide!

Company Profile

Omnia Molecular uses its proprietary platform and design expertise to synthesize and develop novel anti-infectives targeted at difficult-to-treat infections

Click on the slide!

Technology Platform

The speed and focus of our targeted, proprietary platform dramatically reduces development time for anti-infectives and increases the probability of success

Click on the slide!

Development Programs

Our lead program is progressing 3 families of compounds against ESKAPE pathogens with the goal of building a pre-clinical package for out-licencing

Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks